“Real-World Efficacy of Ramucirumab Plus Paclitaxel With or Without Nivolumab in Advanced Gastric and Gastroesophageal Junction Cancers”. Annals of Medical Research, vol. 33, no. 3, Mar. 2026, pp. 091-8, http://www.annalsmedres.org/index.php/aomr/article/view/4905.